Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $28.02 USD
Change Today +0.005 / 0.02%
Volume 50.0K
PHGFF On Other Exchanges
Symbol
Exchange
New York
EN Amsterdam
OTC US
Xetra
BrsaItaliana
EN Amsterdam
As of 11:38 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

koninklijke philips nv (PHGFF) Snapshot

Open
$28.02
Previous Close
$28.01
Day High
$28.02
Day Low
$28.02
52 Week High
08/27/14 - $30.80
52 Week Low
07/7/15 - $24.94
Market Cap
26.7B
Average Volume 10 Days
21.1K
EPS TTM
--
Shares Outstanding
952.5M
EX-Date
05/11/15
P/E TM
--
Dividend
$0.81
Dividend Yield
3.19%
Current Stock Chart for KONINKLIJKE PHILIPS NV (PHGFF)

koninklijke philips nv (PHGFF) Related Bloomberg News

View More Bloomberg News

koninklijke philips nv (PHGFF) Details

Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, including radiation oncology and portfolio management; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products. The company also offers enterprise patient monitoring solutions for clinical information at the patient’s bedside; patient analytics, patient monitoring, and clinical decision support systems; mother and child care products; therapeutic care products; imaging informatics for radiology and cardiology; picture archiving and communication systems and integrated electronic medical record systems; professional services; clinical support and performance, education, value-added services, installation, and remote proactive monitoring services; and care coordination, home monitoring, and care solutions. In addition, it provides mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Further, the company is involved in the development, manufacture, and application of various lighting products and services, including light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; functional, decorative, lifestyle, and scene-setting luminaires; and controls and luminaires for city beautification, road and sports lighting, office lighting, shop/hospitality lighting, and industry lighting. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is based in Amsterdam, the Netherlands.

92,121 Employees
Last Reported Date: 07/27/15
Founded in 1891

koninklijke philips nv (PHGFF) Top Compensated Officers

Chairman of the Board of Management, Chief Ex...
Total Annual Compensation: €1.5M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €869.1K
Executive Vice-President, Member of Board of ...
Total Annual Compensation: €901.9K
Compensation as of Fiscal Year 2014.

koninklijke philips nv (PHGFF) Key Developments

Koninklijke Philips N.V Announces Earnings Results for the Second Quarter of 2015; Provides Earnings Guidance for the Year 2015 and 2016

Koninklijke Philips N.V announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, adjusted earnings before interest, taxes and amortization rose 27% to EUR 501 million ($550 million). Sales jumped 20% to EUR 5.97 billion from EUR 4.97 billion in the prior year. The net profit attributable to shareholders was EUR 272 million ($301 million) or EUR 0.30 per diluted share against EUR 242 million or EUR 0.26 per diluted share for the same period a year ago. Income from operations was EUR 349 million against EUR 291 million for the same period a year ago. Income before taxes was EUR 275 million against EUR 217 million for the same period a year ago. Net income from continuing operations was EUR 226 million against EUR 188 million for the same period a year ago. Net cash provided by operating activities was EUR 186 million against EUR 410 million for the same period a year ago. Net capital expenditures were EUR 216 million against EUR 196 million for the same period a year ago. At the end of the second quarter of 2015, Philips had a net debt position of EUR 4,545 million, compared to EUR 2,333 million at the end of the second quarter of 2014. Free cash outflow was EUR 30 million, compared to a free cash inflow of EUR 214 million in the second quarter of 2014. EBITA was EUR 450 million against EUR 368 million for the same period a year ago. For the six months, the company reported sales of EUR 11,313 million against EUR 3,975 million for the same period a year ago. Income from operations was EUR 488 million against EUR 463 million for the same period a year ago. Income before taxes was EUR 347 million against EUR 320 million for the same period a year ago. Net income from continuing operations was EUR 290 million against EUR 284 million for the same period a year ago. Net income attributable to the company shareholders was EUR 371 million or EUR 0.41 per diluted share against EUR 380 million or EUR 0.40 per diluted share for the same period a year ago. Net cash provided by operating activities was EUR 70 million against net cash used for by operating activities of EUR 137 million for the same period a year ago. Net capital expenditures were EUR 403 million against EUR 354 million for the same period a year ago. EBITA was EUR 680 million against EUR 621 million for the same period a year ago. The company expects to turn in modest sales growth this year and improve its operational performance in both 2015 and 2016.

Philips Mulls Sale Of Lighting Division

Koninklijke Philips N.V (ENXTAM:PHIA) may sell unit. The company is looking to divest its lighting division through either a sale or a stock market flotation.

Profound Medical Signs Joint Development Agreement with Royal Philips on Prostate Cancer Treatment

Profound Medical Corp. has inked a joint development agreement with Royal Philips to help the company's proprietary TULSA (Transurethral Ultrasound Ablation) technology designed to treat patients with prostate cancer on Philips' Ingenia and Achieva 3T MRI systems. It is explained that Profound's TULSA technology is emerging as a new minimally invasive, whole gland ablation of the prostate. It has the potential for outcomes comparable to the best of current treatment options, but with lower rates of side effects and higher quality of life for patients.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHGFF:US $28.02 USD +0.005

PHGFF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bridgestone Corp ¥4,721 JPY -2.00
Eaton Corp PLC $60.09 USD -0.17
FUJIFILM Holdings Corp ¥4,941 JPY -31.50
Linde AG €175.68 EUR +1.85
Mitsubishi Electric Corp ¥1,317 JPY -14.00
View Industry Companies
 

Industry Analysis

PHGFF

Industry Average

Valuation PHGFF Industry Range
Price/Earnings 100.0x
Price/Sales 1.0x
Price/Book 2.0x
Price/Cash Flow 58.6x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE PHILIPS NV, please visit www.philips.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.